Boehringer, Hospira Products Adulterated, FDA Warns
The U.S. Food and Drug Administration on Tuesday released warning letters it sent to generic-drug maker Hospira Inc. and German pharmaceutical company Boehringer-Ingelheim Pharma GmbH & Co. KG warning the companies...To view the full article, register now.
Already a subscriber? Click here to view full article